作者: B. Haynes
关键词:
摘要: Development of a preventive immunogen for human immunodeficiency virus (HIV) infection is national priority. The complexities associated with HIV host-virus interactions, coupled the rapid progression epidemic worldwide, have necessitated lowering expectations an vaccine that 100 percent effective and raised important scientific nonscientific issues regarding development use therapeutic vaccines.